Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (2) Janz, Martin Dr. (10) Kammertöns, Thomas Dr. (5) Kirchner, Marieluise Dr. (3) Kopp, Joachim Dr. (1) Landthaler, Markus Prof. Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (2) Mathas, Stephan Dr. (9) Pezzutto, Antonio Prof. Dr. (1) Pombo, Ana Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (13) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (1) Wolf, Jana Prof. Dr. (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (12) (-) Lusatis, Simone (1) (-) Biologie maligner Lymphome (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (12) Tumorgenetik und zelluläre Stressantworten (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (2) 2007 (5) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (5) (-) 2012 (6) 2013 (11) 2014 (4) 2015 (3) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (5) 2024 (2) 13 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Lusatis, SimoneBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 200620112012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein 01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens 01. Oktober 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
01. Oktober 2012 / Transgenic Res Depot formation of doxycycline impairs Tet-regulated gene expression in vivo K. Anders C. Buschow J. Charo T. Blankenstein
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
01. Oktober 2012 / Int J Cancer B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin) T. Kammertoens Z. Qin D. Briesemeister A. Bendelac T. Blankenstein